Old Web
English
Sign In
Acemap
>
authorDetail
>
John E. Jett
John E. Jett
Atopic dermatitis
Medicine
Acetylcholine receptor
Metabolism
Pharmacophore
4
Papers
69
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: The Pivotal Phase 3 ADORING Clinical Program
2021
Lawrence Eichenfeld
Jonathan I. Silverberg
Robert Bissonnette
Anna M. Tallman
David Rubenstein
Stephen C. Piscitelli
John E. Jett
Show All
Source
Cite
Save
Citations (0)
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.
2021
American Journal of Clinical Dermatology
John E. Jett
Michael Mclaughlin
Mark S. Lee
Lawrence Charles Parish
Janet DuBois
Tooraj Joseph Raoof
Glenn Tabolt
Timothy Wilson
Matthew C. Somerville
Wayne DellaMaestra
Stephen C. Piscitelli
Show All
Source
Cite
Save
Citations (0)
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
2016
Schizophrenia Bulletin
David Walling
Stephen R. Marder
John M. Kane
W. Wolfgang Fleischhacker
Richard S.E. Keefe
David A. Hosford
Chris Dvergsten
Anthony Carl Segreti
Jessica S. Beaver
Steven M. Toler
John E. Jett
Geoffrey Dunbar
Show All
Source
Cite
Save
Citations (66)
Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs)
2014
European Journal of Medicinal Chemistry
Jon-Paul Strachan
David C. Kombo
Anatoly Mazurov
Ronald Heemstra
Balwinder Singh Bhatti
Rao Akireddy
Srinivasa V Murthy
Lan Miao
John E. Jett
Jason Speake
Merouane Bencherif
Show All
Source
Cite
Save
Citations (3)
1